AtriCure, Inc.·4

Jul 28, 8:39 AM ET

Dahlquist Karl S. 4

4 · AtriCure, Inc. · Filed Jul 28, 2023

Insider Transaction Report

Form 4
Period: 2023-07-26
Dahlquist Karl S.
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2023-07-26$57.09/sh3,417$195,07732,037 total
Footnotes (2)
  • [F1]These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.
  • [F2]This transaction was executed in multiple trades at prices ranging from $56.75 to $57.50 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    wk-form4_1690547968.xmlPrimary

    FORM 4